Cited by 150Mesenchymal stem cell researchMultiple Sclerosis Research StudiesExtracellular vesicles in disease

The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.

Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Open access

Staff, Nathan P., Jones, David T., Singer, Wolfgang·2019·Mayo Clinic Proceedings

DOI 10.1016/j.mayocp.2019.01.001PMC PMC6643282

Open this paper in CoChat — free account

Abstract

Mesenchymal stromal cells are multipotent cells that are being used to treat a variety of medical conditions. Over the past decade, there has been considerable excitement about using MSCs to treat neurodegenerative diseases, which are diseases that are typically fatal and without other robust therapies. In this review, we discuss the proposed MSC mechanisms of action in neurodegenerative diseases, which include growth factor secretion, exosome secretion, and attenuation of neuroinflammation. We then provide a summary of preclinical and early clinical work on MSC therapies in amyotrophic lateral sclerosis, multiple system atrophy, Parkinson disease, and Alzheimer disease. Continued rigorous and controlled studies of MSC therapies will be critical in order to establish efficacy and protect patients from possible untoward effects.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.mayocp.2019.01.001

Cites

193 of 193 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

DJ-1 Modulates α-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70
Batelli, S., Albani, D., Rametta, R., Polito, L., Prato, F., Pesaresi, M., Negro, A., & Forloni, G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001884 · Cited by 130
Retracted
Conversion of Human Umbilical Cord Mesenchymal Stem Cells in Wharton’s Jelly to Dopamine Neurons Mediated by the Lmx1a and Neurturin In Vitro: Potential Therapeutic Application for Parkinson’s Disease in a Rhesus Monkey Model
Yan, M., Sun, M., Zhou, Y., Wang, W., He, Z., Tang, D., Lu, S., Wang, X., Li, S., Wang, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064000 · Cited by 76
Retracted
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
Second consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Dürr, A., Fowler, C. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000324625.00404.15 · Cited by 3,140

Flagged first, then by citations

Show all 193 references

Sorted by citations

Items 101–150 of 150

Stem Cell Therapies as a Therapeutic Option to Counter Chemo Brain: A Negative Effect of Cancer Treatment
Srivastava, R. K., & Singh, P. (2020) · Regenerative Medicine · doi:10.2217/rme-2020-0060 · Cited by 7
Neurologic Therapeutics in 2035
Johnson, N. E., & Greene, E. P. (2021) · Neurology · doi:10.1212/wnl.0000000000012976 · Cited by 6
Treating Parkinson Disease with Autologous Telomerase-Positive Stem Cells, Update 2021
Young, W., & Speight, M. O. (2021) · Stem Cell & Regenerative Medicine · doi:10.33425/2639-9512.1059 · Cited by 6
iPSCs-derived mesenchymal stromal cells mitigate anxiety and neuroinflammation in aging female mice
Wei, X., Li, R., Li, X., Wang, B., Huang, J., Mu, H., Zhang, Q., Zhang, Z., Ru, Y., Wu, X., et al. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106347 · Cited by 6
Bioinspired and Biomimetic Systems: Cell–Derived Vesicles as Drug Carriers for Targeted Delivery in Neurodegenerative Disorders
Holghoomi, R., Rahdar, A., Kadkhoda, J., Mohammadzadeh, V., Shirzad, M., Salehi, B., Ebrahimi, M.-S., & Pandey, S. (2026) · Nano LIFE · doi:10.1142/s179398442630013x · Cited by 6
Non-pharmacological therapeutic paradigms in stress-induced depression: from novel therapeutic perspective with focus on cell-based strategies
Azarfarin, M., Shahla, M. M., Mohaddes, G., & Dadkhah, M. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2024.39 · Cited by 5
The Impact of Umbilical Cord Mesenchymal Stem Cells on Motor Function in Children with Cerebral Palsy: Results of a Real-world, Compassionate use Study
Chrościńska–Krawczyk, M., Zdolińska-Malinowska, I., & Boruczkowski, D. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10742-2 · Cited by 5
New perspectives for mesenchymal stromal cells as an adjuvant therapy for infectious disease-associated encephalopathies
Maron‐Gutierrez, T., Lima, M., & Barbosa‐Silva, M. C. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.314292 · Cited by 5
The Evolving Landscape of Stem Cell Therapies for Huntington’s Disease
Estarellas, M., Gomis, C., & Canals, J. M. (2025) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-025-00816-3 · Cited by 4
Multi-faceted characterization of mesenchymal stem cells and their application as a powerful tool for agrobiotechnology, assisted reproductive technologies, and veterinary and regenerative biomedicine – a review
Romanek, J., Trzcińska, M., & Samiec, M. (2023) · Annals of Animal Science · doi:10.2478/aoas-2023-0055 · Cited by 4
Post-symptomatic administration of hMSCs exerts therapeutic effects in SCA2 mice
Kim, S., Sharma, C., Hong, J., Kim, J.-H., Nam, Y., Kim, M. S., Lee, T. Y., Kim, K., Suk, K., Lee, H., et al. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04020-8 · Cited by 4
Therapeutic strategies for intervertebral disc degeneration: Extracellular vesicles and microRNAs derived from mesenchymal stem cells
Lim, Y., Seo, M., Park, S., & Lee, G. W. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i7.107212 · Cited by 4
Advancements in Autologous Stem Cell Transplantation for Parkinson’s Disease
Shi, J., & Zhang, K.-Z. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x19666230907112413 · Cited by 5
Development and characterization of islet‐derived mesenchymal stem cells from clinical grade neonatal porcine cryopreserved islets
Kikuchi, T., Nishimura, M., Komori, N., Iizuka, N., Otoi, T., & Matsumoto, S. (2023) · Xenotransplantation · doi:10.1111/xen.12831 · Cited by 4
Autophagy reprogramming stem cell pluripotency and multiple-lineage differentiation
Yang, Y., Lai, W., Lin, T.-W., Lin, Y., Chien, Y., Tsai, Y., Tai, H., Wang, C.-L., Liu, Y.-Y., Huang, P., et al. (2022) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000728 · Cited by 4
Mesenchymal Stem Cell Transplantation Ameliorates Ara-C-Induced Motor Deficits in a Mouse Model of Cerebellar Ataxia
Park, N. R., Sharma, C., Jung, U. J., Kim, S., Nam, Y., Kim, K., Suk, K., Lee, H., & Kim, S. R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12051756 · Cited by 4
The Emerging Role of Curcumin in Inducing Neuronal Trans-differentiation of Mesenchymal Stem Cells: a Review
Cynthia, C., Jain, S. M., Paul, S., Pathak, S., & Banerjee, A. (2023) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-023-00300-6 · Cited by 4
Multiple System Atrophy
Zamora, C. A., Muhleman, M., & Castillo, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-82367-2_31 · Cited by 3
Network Meta-Analysis of Stem Cell Therapies for Parkinson’s Disease: Exploring the Optimal Strategy Based on Animal Models
Zhang, Z., Wang, Y., Zhang, Z., & Qi, Z. (2025) · Stem Cells and Development · doi:10.1089/scd.2025.0056 · Cited by 2
Intraspinal Cavity Injection of Human Mesenchymal Stem Cells and Tracking their Migration into the Rat Brain
Kim, H., Lee, S., Chang, J. W., Kim, A. R., Jang, H., & Na, D. L. (2021) · Journal of Visualized Experiments · doi:10.3791/62120 · Cited by 2
Neuroprotective effect of human cord blood-derived extracellular vesicles by improved neuromuscular function and reduced gliosis in a rat model of Huntington's disease
Bahar, R., Darabi, S., Norouzian, M., Roustaei, S., Torkamani-dordshaikh, S., Hasanzadeh, M., Vakili, K. G., Fathi, M., Khodagholi, F., Kaveh, N., et al. (2024) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2024.102419 · Cited by 2
Intravenous MSC-Treatment Improves Impaired Brain Functions in the R6/2 Mouse Model of Huntington’s Disease via Recovered Hepatic Pathological Changes
Yu-Taeger, L., El-Ayoubi, A., Qi, P., Danielyan, L., & Nguyen, H. P. (2024) · Cells · doi:10.3390/cells13060469 · Cited by 1
Cellular Immunotherapies for Multiple Sclerosis: Mechanistic Insights and Clinical Advances
Васильевич, К. В., Fisher, M. S., Облеухова, И. А., & Sennikov, S. V. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020585 · Cited by 2
Introduction aux cellules souches
Michel, L. (2023) · Pratique Neurologique - FMC · doi:10.1016/j.praneu.2023.01.006 · Cited by 1
Effects of the Co-Overexpression of the BCL and BDNF Genes on the Gamma-Aminobutyric Acid-Ergic Differentiation of Wharton’s-Jelly-Derived Mesenchymal Stem Cells
Borkowska, P., Morys, J., Zielińska, A., & Kowalski, J. (2023) · Biomedicines · doi:10.3390/biomedicines11061751 · Cited by 1
Stem cell-based therapy for neurodegenerative disorders: progress and challenges
Narayanan, S., Paramshetti, S., Angolkar, M., Gangadharappa, H. V., Vaijanathappa, J., Ambhore, N. S., Haripriya, G., Osmani, R. A. M., & Spandana, K. M. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00025-8 · Cited by 1
Mesenchymal Stem/Stromal Cells and Hydrogel Scaffolds for Tissue Engineering
Zhang, L., & Han, Z. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101793 · Cited by 1
Perspectives of Stem Cell Therapy: A Promising Therapeutic for Cancer Model and Alzheimer’s Disease
Jeyachandran, S., Ganesan, G., Sangeetha, R., Paramasivan, V., Subbaraj, G. K., & Kulanthaivel, L. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_32 · Cited by 1
Mesenchymal stem cell-derived exosomes inhibit Aβ1-42 induced microglia polarization by TLR2/MYD88/NF-κB pathwayPreprint
Yin, Z., Guo, M., Wang, D., Han, Z., Hu, T., Wang, Y., Xiong, X., Ge, X., Wang, L., Zhang, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-416793/v1
New Prospects for Stem Cell Therapy in Alzheimer’s Disease
Jiang, K., Zhu, Y., & Zhang, L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100334
Current Trends of Stem Cells in Neurodegenerative Diseases
Tsagkaris, C., Moysidis, D. V., Papazoglou, Α. S., Khan, A., Papadakos, S. P., Louka, A. M., Scordilis, D. M., Shkodina, A. D., Varmpompiti, K., Batiha, G. E., et al. (2022) · Nutritional neurosciences · doi:10.1007/978-981-15-9781-7_14
Drug interventions and stem cells in traumatic brain injury: Translation from experimental model to bedside
Tabet, M., Reslan, M. A., Haidar, M. A., Issa, H., Dor, M. E., Abedi, R., Nasrallah, L., Eid, A. H., Zibara, K., & Kobeissy, F. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823347-4.00012-9
Perspectives of Stem Cell Therapy: A Promising Therapeutic for Cancer Model and Alzheimer’s Disease
Jeyachandran, S., Ganesan, G., Sangeetha, R., Paramasivan, V., Subbaraj, G. K., & Kulanthaivel, L. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_32-1
Development of Mesenchymal Stem Cells Therapy for the Treatment of Polyglutamine SCA: From Bench to Bedside
Ho, C., Lai, H.-Y., Wang, L.-M., & Soong, B. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24345-5_19
Mesenchymal stem cell-derived exosomes as a new possible therapeutic strategy for Parkinson’s disease
Zhang, Z., Kong, J., & An, S. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001990
Analysis of Inward Vascular Remodeling Focusing on Endothelial–Perivascular Crosstalk in a Microfluidic Device
Murai, R., Watanabe, M., & Sudo, R. (2023) · Journal of Robotics and Mechatronics · doi:10.20965/jrm.2023.p1165 · Cited by 1
Análise proteômica no líquor de doentes com a Esclerose Lateral Amiotrófica que receberam infusão de células-tronco mesenquimais
Reis, A. L. G. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2024.tde-07052024-162252
Hematopoietic (stem) cells—The elixir of life?
Cerezo, E. L., Anderson, J., Vedrenne, E. D., Martín, N. Y., & Lengefeld, J. (2025) · FEBS Letters · doi:10.1002/1873-3468.70215
Additional file 2 of Menstrual blood-derived endometrial stem cells alleviate neuroinflammation by modulating M1/M2 polarization in cell and rat Parkinson’s disease models
Li, H., Wei, J., Zhang, Z., Li, J., Ma, Y., Zhang, P., & Lin, J. (2023) · Figshare · doi:10.6084/m9.figshare.22631427
Additional file 1 of Menstrual blood-derived endometrial stem cells alleviate neuroinflammation by modulating M1/M2 polarization in cell and rat Parkinson’s disease models
Li, H., Wei, J., Zhang, Z., Li, J., Ma, Y., Zhang, P., & Lin, J. (2023) · Figshare · doi:10.6084/m9.figshare.22631424
Additional file 3 of Menstrual blood-derived endometrial stem cells alleviate neuroinflammation by modulating M1/M2 polarization in cell and rat Parkinson’s disease models
Li, H., Wei, J., Zhang, Z., Li, J., Ma, Y., Zhang, P., & Lin, J. (2023) · Figshare · doi:10.6084/m9.figshare.22631430
BM-derived mesenchymal stem cell microvesicles protect enteric neural precursor cells and alleviate diabetes-associated enteric neuropathy
Shi, H., Yao, H., Liu, Y., Fan, M., Cai, S., Xu, S., Jiang, C., Zhang, Y., Jiang, W., Qian, W., et al. (2026) · Journal of Clinical Investigation · doi:10.1172/jci192437
Hypoxia-conditioned MSC secretome attenuates CD38 expression and cellular senescence in a diabetic rat brain model
Wilaksono, B., Putra, A., Chodidjah, Syamsunarno, M. R. A. A., Subchan, P., Sumarawati, T., Hidayah, N., & Nazar, M. A. (2026) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2026.034.1.20
Étude de la propagation de l'alpha-synucléine de l'hôte vers le greffon dans la maladie de Parkinson
Patrigeon, M. (2022) · theses.fr (ABES) · doi:10.70675/8d75463az5b67z46bfz8649zc3e016dabdda
Models of neuroprotection in Parkinson's disease: Exploring cellular, molecular, and microenvironmental targets
Álvarez‐Luquín, D. D., González-Fernández, R. R., Ichikawa-Escamilla, E., Torres-Velasco, M. E., Martínez-Martínez, E. J., Arce-Sillas, A., Juárez-Vaquera, V. H., Miranda-Narváez, C. L., Hernández, M., & Adalid-Peralta, L. V. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115764
Cell therapy in multiple sclerosis: An overview
Michel, L. (2026) · Revue Neurologique · doi:10.1016/j.neurol.2026.03.012
Translational potential of GMP-grade human umbilical cord-derived mesenchymal stem cells (UC-MSCs) in traumatic spinal cord injury: a preclinical study in rat
Han, Z., Yu, H., Du, W., Gao, Y., Pan, K., Jia, H., Zhao, M., Wei, Z., Yan, S., Wang, Y., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08373-x · Cited by 1
Mesenchymal stromal cells in age-related neurodegenerative disorders: mechanisms, translational barriers, and precision strategies
Long, Z., Guo, H., & Sun, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1965598
The Effect of Chronic Inflammation on Cellular Aging Processes and Current Treatment Approaches
Başaran, A. (2026) · Uluslararası Sağlık Bilimlerinde Disiplinler Arası Etkileşim Dergisi · doi:10.65349/nxpt1964
Stem Cell-Based Therapies in Companion Animals: Molecular Mechanisms, Clinical Applications, and Translational Perspectives
Liu, W., Wang, Y., An, W., Wang, X., Han, B., Tao, H., 张永利, Gong, F., Wang, X., & Wang, J. (2026) · Cells · doi:10.3390/cells15201884

Authors: Staff, N. P., Jones, D. T., & Singer, W.
Affiliations: Mayo Clinic (US)
Corresponding author: Staff, Nathan P.
ORCID: Staff, Nathan P.
Jones, David T.
Singer, Wolfgang
Venue: Mayo Clinic Proceedings
Publisher: Elsevier BV
Published: 2019-05
Volume: 94
Issue: 5
Pages: 892-905
ISSN: 0025-6196 (ISSN-L)
DOI: 10.1016/j.mayocp.2019.01.001
PMC: PMC6643282
OpenAlex: W2943517835
Cited by: 150
References: 193
Citations by year: 2026: 10 · 2025: 7 · 2024: 18 · 2023: 38 · 2022: 26 · 2021: 26 · 2020: 23 · 2019: 2
FWCI: 2.34
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (am, 365 d)
Locations: Mayo Clinic Proceedings (acceptedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Food and Drug Administration (R01 FD004789)
National Cancer Institute (R01CA211887)
National Institute of Neurological Disorders and Stroke (U54NS065736, R01NS092625)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Keywords: mesenchymal stem cells, neurodegenerative diseases, amyotrophic lateral sclerosis, multiple system atrophy, Parkinson's disease, Alzheimer's disease, growth factor secretion, exosomes, neuroinflammation
MeSH terms: Alzheimer Disease, Amyotrophic Lateral Sclerosis, Animals, Clinical Trials as Topic, Humans, Parkinson Disease, Multiple System Atrophy, Mesenchymal Stem Cell Transplantation, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks